Case demonstrates hair growth in adolescent with alopecia areata via dupilumab, suggesting a new treatment option.
This case demonstrates the potential use of dupilumab, which has a well-established safety profile, for pediatric patients with AA and its ability to initiate and sustain hair growth for the long term. Dermatologists may consider dupilumab for patients with AA and comorbid AD that have failed a variety of treatments from several drug classes. .
No takes yet. Share an insight, caveat, or question.
Velaoras et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: